Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Relationship between Fusion Genes and MicroRNAs in Cancer. | Cells | 2023 | 37887311 | PubTator, text mining | PubMed |
| Understanding blood development and leukemia using sequencing-based technologies and human cell systems. | Front Mol Biosci | 2023 | 37886034 | PubTator, text mining | PubMed |
| Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience. | Cureus | 2023 | 37885525 | PubTator, text mining | PubMed |
| A Rare Case of Therapy-Related B-cell Acute Lymphoblastic Leukemia Arising From Acute Myeloid Leukemia. | Cureus | 2023 | 37872919 | PubTator, text mining | PubMed |
| A guide to epigenetics in leukaemia stem cells. | Mol Oncol | 2023 | 37872885 | PubTator, text mining | PubMed |
| Hema-seq reveals genomic aberrations in a rare simultaneous occurrence of hematological malignancies. | Cell Rep Methods | 2023 | 37852254 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition. | Hemasphere | 2023 | 37841755 | PubTator, text mining | PubMed |
| SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer. | Cancers (Basel) | 2023 | 37835502 | PubTator, text mining | PubMed |
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia using Flow Cytometry. | bioRxiv | 2023 | 37808719 | PubTator, text mining | PubMed |
| [Clinical features and prognosis of core binding factor acute myeloid leukemia children in South China: a multicenter study]. | Zhonghua Er Ke Za Zhi | 2023 | 37803854 | PubTator, text mining | PubMed |
| [ST13-PDGFRβ positive acute myeloid leukaemia: a case report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803843 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | J Exp Clin Cancer Res | 2023 | 37803464 | PubTator, text mining | PubMed |
| Distinct and targetable role of calcium-sensing receptor in leukaemia. | Nat Commun | 2023 | 37802982 | PubTator, text mining | PubMed |
| Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. | Nat Commun | 2023 | 37798266 | PubTator, text mining | PubMed |
| c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights. | Onco Targets Ther | 2023 | 37790582 | PubTator, text mining | PubMed |
| Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia. | Res Sq | 2023 | 37790524 | PubTator, text mining | PubMed |
| ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair. | J Exp Clin Cancer Res | 2023 | 37775817 | PubTator, text mining | PubMed |
| Targeting cis-regulatory elements of FOXO family is a novel therapeutic strategy for induction of leukemia cell differentiation. | Cell Death Dis | 2023 | 37773170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=11